| Takeda Pharma AG - Elvanse 70 mg, Hartkapseln | | 63023 | | 03 | | Elvanse 70 mg | | Hartkapseln | | N06BA12 | | | | 27.03.2014 | | |
| | Composition | | lisdexamfetamini dimesilas 70 mg corresp. dexamfetaminum 20.8 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 127, E 133, E 171, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.3588 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| | 70 mg correspond 20.8 mg |
| | BAG: Principe actif | Concentr. |
|---|
| | 70 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| | | | | | | | | | | | | | | color. | | | | color. | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | | | | | | Drucktinte | | | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 30 Gélule(s) | 114.64 | 141.10 | A+ | LS | Non |
|
|
